Anemia is more common in later-stage chronic kidney disease (CKD), with diabetes and dialysis increasing the risk. Treating the underlying cause can improve symptoms and quality of life.

Iron deficiency may also play an important role in this anemia because improvement in CHF has been seen with IV iron treatment alone. We call the interaction between chronic renal failure ...

If chronic kidney disease (CKD) is left untreated, it can lead to complications like anemia and high blood pressure, which can worsen kidney function and contribute to other health issues.

Chronic kidney disease and anemia—both individually and together—spell bad news (in the form of increased mortality risk) for patients with heart failure, say the results of a new study of ...

KDOQI (2007) KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 50: 471–530 National ...

Patients with CKD are at elevated risk for zinc deficiency, which has been linked with an increased risk for CKD progression and kidney failure. Zinc, a trace mineral integral to numerous ...

The marketing of darbepoetin alfa is currently approved for the treatment of anemia associated with CKD, including patients ... were to evaluate ESA-use patterns in both outpatient and inpatient ...

Akebia announced the collaborative trial initiation in September 2024. "We look forward to begin treating CKD anemia patients on dialysis with Vafseo ahead of its anticipated market launch in ...

Patients with symptomatic anemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also receive vadadustat instead of an erythropoiesis-stimulating agent such ...

Outcomes study will assess mortality and hospitalization in patients treated with Vafseo compared to current standard of care "We look forward to begin treating CKD anemia patients on dialysis ...

Inc.) Vafseo was approved by the U.S. Food and Drug Administration in March 2024 for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at ...

Akebia announced the collaborative trial initiation in September 2024. "We look forward to begin treating CKD anemia patients on dialysis with Vafseo ahead of its anticipated market launch in January ...